Zaklad LeczniczoDiagnostyczny Chorob Ukladu Nerwowego Neurom Company Profile - Poland | Financials & Key Executives

Zaklad LeczniczoDiagnostyczny Chorob Ukladu Nerwowego Neuromag Sp. z o.o. is based in Poland. The head office is in Zawiercie. It operates in the General Medical and Surgical Hospitals industry. The enterprise was incorporated on February 27, 2017. There was a net sales revenue increase of 13.83% reported in Zaklad LeczniczoDiagnostyczny Chorob Ukladu Nerwowego Neuromag Sp. z o.o.’s latest financial highlights for 2022. Its’ total assets recorded a growth of 39.64%. The net profit margin of Zaklad LeczniczoDiagnostyczny Chorob Ukladu Nerwowego Neuromag Sp. z o.o. decreased by 0.54% in 2022.

Headquarters
Ul. Pilsudskiego 80
Zawiercie; Slaskie;

Contact Details: Purchase the Zaklad LeczniczoDiagnostyczny Chorob Ukladu Nerwowego Neuromag Sp. z o.o. report to view the information.

Website: http://www.neuromag.med.pl

Basic Information

Outstanding Shares:

Purchase the Zaklad LeczniczoDiagnostyczny Chorob Ukladu Nerwowego Neuromag Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Zaklad LeczniczoDiagnostyczny Chorob Ukladu Nerwowego Neuromag Sp. z o.o. report to view the information.

Incorporation Date:

February 27, 2017

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Management Board Member

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Zaklad LeczniczoDiagnostyczny Chorob Ukladu Nerwowego Neuromag Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

13.83%▲

Total operating revenue

9.23%▲

Operating profit (EBIT)

6.9%▲

Net Profit (Loss) for the Period

-4.3%▼

Total assets

39.64%▲

Total equity

40.9%▲

Operating Profit Margin (ROS)

-0.21%▼

Net Profit Margin

-0.54%▼

Return on Equity (ROE)

-13.71%▼

Debt to Equity Ratio

-7.2%▼

Quick Ratio

0.05%▲

Cash Ratio

0.3%▲

Zaklad LeczniczoDiagnostyczny Chorob Ukladu Nerwowego Neuromag Sp. z o.o. (Poland)